The prevalence of dyslipidemia and IGT in the Non-MS group was lower than that of the MS group; however, LDL, HbA1c, and UA were significant factors of NAFLD having elevation of ALT in the Non-MS group. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.